chlordiazepoxide has been researched along with Obesity in 5 studies
Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MELDMAN, MJ | 1 |
| MATLIN, E | 1 |
| SETTEL, E | 1 |
| Fieldstone, A | 1 |
| Zipf, WB | 1 |
| Sarter, MF | 1 |
| Berntson, GG | 1 |
| Plauchu, M | 1 |
| Arnaud, P | 1 |
| Pousset, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome[NCT05541003] | Phase 2 | 12 participants (Actual) | Interventional | 2023-01-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for chlordiazepoxide and Obesity
| Article | Year |
|---|---|
Food intake in Prader-Willi syndrome and controls with obesity after administration of a benzodiazepine receptor agonist.
Topics: Adolescent; Adult; Child; Chlordiazepoxide; Eating; Female; GABA-A Receptor Agonists; Humans; Male; | 1998 |
4 other studies available for chlordiazepoxide and Obesity
| Article | Year |
|---|---|
PRR STUDY NO. 3. (A METHOD FOR CONTROLLING THE ADMINISTRATION OF TRANYLCYPROMINE).
Topics: Alcoholism; Anxiety; Anxiety Disorders; Chlordiazepoxide; Depression; Depressive Disorder; Drug Ther | 1964 |
Use of chlordiazepoxide in obese patients.
Topics: Amphetamine; Amphetamines; Benzyl Compounds; Chlordiazepoxide; Diet, Reducing; Humans; Obesity | 1963 |
Combined d-amphetamine and chlordiazepoxide therapy in the emotionally disturbed obese patient.
Topics: Amphetamine; Amphetamines; Chlordiazepoxide; Dextroamphetamine; Mental Disorders; Obesity | 1963 |
[Value of chlordiazepoxide in the treatment of simple or complicated obesity in benign fat diabetes].
Topics: Adolescent; Adult; Aged; Chlordiazepoxide; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Obe | 1966 |